Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.

Identifieur interne : 000433 ( Main/Exploration ); précédent : 000432; suivant : 000434

Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.

Auteurs : Laura Hulea [Canada] ; Simon-Pierre Gravel [Canada] ; Masahiro Morita [Japon] ; Marie Cargnello [France] ; Oro Uchenunu [Canada] ; Young Kyuen Im [Canada] ; Camille Lehuédé [Canada] ; Eric H. Ma [Canada] ; Matthew Leibovitch [Canada] ; Shannon Mclaughlan [Canada] ; Marie-José Blouin [Canada] ; Maxime Parisotto [Canada] ; Vasilios Papavasiliou [Canada] ; Cynthia Lavoie [Canada] ; Ola Larsson [Suède] ; Michael Ohh [Canada] ; Tiago Ferreira [Canada] ; Celia Greenwood [Canada] ; Gaëlle Bridon [Canada] ; Daina Avizonis [Canada] ; Gerardo Ferbeyre [Canada] ; Peter Siegel [Canada] ; Russell G. Jones [Canada] ; William Muller [Canada] ; Josie Ursini-Siegel [Canada] ; Julie St-Pierre [Canada] ; Michael Pollak [Canada] ; Ivan Topisirovic [Canada]

Source :

RBID : pubmed:30244971

Descripteurs français

English descriptors

Abstract

There is increasing interest in therapeutically exploiting metabolic differences between normal and cancer cells. We show that kinase inhibitors (KIs) and biguanides synergistically and selectively target a variety of cancer cells. Synthesis of non-essential amino acids (NEAAs) aspartate, asparagine, and serine, as well as glutamine metabolism, are major determinants of the efficacy of KI/biguanide combinations. The mTORC1/4E-BP axis regulates aspartate, asparagine, and serine synthesis by modulating mRNA translation, while ablation of 4E-BP1/2 substantially decreases sensitivity of breast cancer and melanoma cells to KI/biguanide combinations. Efficacy of the KI/biguanide combinations is also determined by HIF-1α-dependent perturbations in glutamine metabolism, which were observed in VHL-deficient renal cancer cells. This suggests that cancer cells display metabolic plasticity by engaging non-redundant adaptive mechanisms, which allows them to survive therapeutic insults that target cancer metabolism.

DOI: 10.1016/j.cmet.2018.09.001
PubMed: 30244971
PubMed Central: PMC7252493


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.</title>
<author>
<name sortKey="Hulea, Laura" sort="Hulea, Laura" uniqKey="Hulea L" first="Laura" last="Hulea">Laura Hulea</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gravel, Simon Pierre" sort="Gravel, Simon Pierre" uniqKey="Gravel S" first="Simon-Pierre" last="Gravel">Simon-Pierre Gravel</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Faculté de Pharmacie, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, QC, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Faculté de Pharmacie, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, QC</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Morita, Masahiro" sort="Morita, Masahiro" uniqKey="Morita M" first="Masahiro" last="Morita">Masahiro Morita</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular Medicine and Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Institute of Resource Developmental and Analysis, Kumamoto University, Kumamoto 860-8111, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Molecular Medicine and Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Institute of Resource Developmental and Analysis, Kumamoto University, Kumamoto 860-8111</wicri:regionArea>
<wicri:noRegion>Kumamoto 860-8111</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cargnello, Marie" sort="Cargnello, Marie" uniqKey="Cargnello M" first="Marie" last="Cargnello">Marie Cargnello</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Centre de Recherche en Cancérologie de Toulouse, 31100 Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Centre de Recherche en Cancérologie de Toulouse, 31100 Toulouse</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
<orgName type="university">Université McGill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Uchenunu, Oro" sort="Uchenunu, Oro" uniqKey="Uchenunu O" first="Oro" last="Uchenunu">Oro Uchenunu</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Im, Young Kyuen" sort="Im, Young Kyuen" uniqKey="Im Y" first="Young Kyuen" last="Im">Young Kyuen Im</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lehuede, Camille" sort="Lehuede, Camille" uniqKey="Lehuede C" first="Camille" last="Lehuédé">Camille Lehuédé</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ma, Eric H" sort="Ma, Eric H" uniqKey="Ma E" first="Eric H" last="Ma">Eric H. Ma</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Leibovitch, Matthew" sort="Leibovitch, Matthew" uniqKey="Leibovitch M" first="Matthew" last="Leibovitch">Matthew Leibovitch</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mclaughlan, Shannon" sort="Mclaughlan, Shannon" uniqKey="Mclaughlan S" first="Shannon" last="Mclaughlan">Shannon Mclaughlan</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Blouin, Marie Jose" sort="Blouin, Marie Jose" uniqKey="Blouin M" first="Marie-José" last="Blouin">Marie-José Blouin</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Parisotto, Maxime" sort="Parisotto, Maxime" uniqKey="Parisotto M" first="Maxime" last="Parisotto">Maxime Parisotto</name>
<affiliation wicri:level="1">
<nlm:affiliation>Département de Chimie, Université de Montréal, Montréal, QC H3C 3J7, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Département de Chimie, Université de Montréal, Montréal, QC H3C 3J7</wicri:regionArea>
<wicri:noRegion>QC H3C 3J7</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Papavasiliou, Vasilios" sort="Papavasiliou, Vasilios" uniqKey="Papavasiliou V" first="Vasilios" last="Papavasiliou">Vasilios Papavasiliou</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lavoie, Cynthia" sort="Lavoie, Cynthia" uniqKey="Lavoie C" first="Cynthia" last="Lavoie">Cynthia Lavoie</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Larsson, Ola" sort="Larsson, Ola" uniqKey="Larsson O" first="Ola" last="Larsson">Ola Larsson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, 171 16 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, 171 16 Stockholm</wicri:regionArea>
<wicri:noRegion>171 16 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ohh, Michael" sort="Ohh, Michael" uniqKey="Ohh M" first="Michael" last="Ohh">Michael Ohh</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Laboratory Medicine and Pathobiology and Department of Biochemistry, University of Toronto, Toronto, ON M5S1A8, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Laboratory Medicine and Pathobiology and Department of Biochemistry, University of Toronto, Toronto, ON M5S1A8</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ferreira, Tiago" sort="Ferreira, Tiago" uniqKey="Ferreira T" first="Tiago" last="Ferreira">Tiago Ferreira</name>
<affiliation wicri:level="1">
<nlm:affiliation>McGill University Centre for Research in Neuroscience, Montreal General Hospital, Montreal, QC H3G 1A4, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>McGill University Centre for Research in Neuroscience, Montreal General Hospital, Montreal, QC H3G 1A4</wicri:regionArea>
<wicri:noRegion>QC H3G 1A4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Greenwood, Celia" sort="Greenwood, Celia" uniqKey="Greenwood C" first="Celia" last="Greenwood">Celia Greenwood</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC H3A 1A3, Canada; Department of Human Genetics, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC H3A 1A3, Canada; Department of Human Genetics, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bridon, Gaelle" sort="Bridon, Gaelle" uniqKey="Bridon G" first="Gaëlle" last="Bridon">Gaëlle Bridon</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Avizonis, Daina" sort="Avizonis, Daina" uniqKey="Avizonis D" first="Daina" last="Avizonis">Daina Avizonis</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ferbeyre, Gerardo" sort="Ferbeyre, Gerardo" uniqKey="Ferbeyre G" first="Gerardo" last="Ferbeyre">Gerardo Ferbeyre</name>
<affiliation wicri:level="1">
<nlm:affiliation>Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, QC H3C 3J7, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, QC H3C 3J7</wicri:regionArea>
<wicri:noRegion>QC H3C 3J7</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Siegel, Peter" sort="Siegel, Peter" uniqKey="Siegel P" first="Peter" last="Siegel">Peter Siegel</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jones, Russell G" sort="Jones, Russell G" uniqKey="Jones R" first="Russell G" last="Jones">Russell G. Jones</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Muller, William" sort="Muller, William" uniqKey="Muller W" first="William" last="Muller">William Muller</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ursini Siegel, Josie" sort="Ursini Siegel, Josie" uniqKey="Ursini Siegel J" first="Josie" last="Ursini-Siegel">Josie Ursini-Siegel</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="St Pierre, Julie" sort="St Pierre, Julie" uniqKey="St Pierre J" first="Julie" last="St-Pierre">Julie St-Pierre</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, Microbiology, and Immunology, Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, Microbiology, and Immunology, Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1H 8M5</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pollak, Michael" sort="Pollak, Michael" uniqKey="Pollak M" first="Michael" last="Pollak">Michael Pollak</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada. Electronic address: michael.pollak@mcgill.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Topisirovic, Ivan" sort="Topisirovic, Ivan" uniqKey="Topisirovic I" first="Ivan" last="Topisirovic">Ivan Topisirovic</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada. Electronic address: ivan.topisirovic@mcgill.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30244971</idno>
<idno type="pmid">30244971</idno>
<idno type="doi">10.1016/j.cmet.2018.09.001</idno>
<idno type="pmc">PMC7252493</idno>
<idno type="wicri:Area/Main/Corpus">000449</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000449</idno>
<idno type="wicri:Area/Main/Curation">000449</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000449</idno>
<idno type="wicri:Area/Main/Exploration">000449</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.</title>
<author>
<name sortKey="Hulea, Laura" sort="Hulea, Laura" uniqKey="Hulea L" first="Laura" last="Hulea">Laura Hulea</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gravel, Simon Pierre" sort="Gravel, Simon Pierre" uniqKey="Gravel S" first="Simon-Pierre" last="Gravel">Simon-Pierre Gravel</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Faculté de Pharmacie, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, QC, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Faculté de Pharmacie, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, QC</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Morita, Masahiro" sort="Morita, Masahiro" uniqKey="Morita M" first="Masahiro" last="Morita">Masahiro Morita</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular Medicine and Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Institute of Resource Developmental and Analysis, Kumamoto University, Kumamoto 860-8111, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Molecular Medicine and Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Institute of Resource Developmental and Analysis, Kumamoto University, Kumamoto 860-8111</wicri:regionArea>
<wicri:noRegion>Kumamoto 860-8111</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cargnello, Marie" sort="Cargnello, Marie" uniqKey="Cargnello M" first="Marie" last="Cargnello">Marie Cargnello</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Centre de Recherche en Cancérologie de Toulouse, 31100 Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Centre de Recherche en Cancérologie de Toulouse, 31100 Toulouse</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
<orgName type="university">Université McGill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Uchenunu, Oro" sort="Uchenunu, Oro" uniqKey="Uchenunu O" first="Oro" last="Uchenunu">Oro Uchenunu</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Im, Young Kyuen" sort="Im, Young Kyuen" uniqKey="Im Y" first="Young Kyuen" last="Im">Young Kyuen Im</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lehuede, Camille" sort="Lehuede, Camille" uniqKey="Lehuede C" first="Camille" last="Lehuédé">Camille Lehuédé</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ma, Eric H" sort="Ma, Eric H" uniqKey="Ma E" first="Eric H" last="Ma">Eric H. Ma</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Leibovitch, Matthew" sort="Leibovitch, Matthew" uniqKey="Leibovitch M" first="Matthew" last="Leibovitch">Matthew Leibovitch</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mclaughlan, Shannon" sort="Mclaughlan, Shannon" uniqKey="Mclaughlan S" first="Shannon" last="Mclaughlan">Shannon Mclaughlan</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Blouin, Marie Jose" sort="Blouin, Marie Jose" uniqKey="Blouin M" first="Marie-José" last="Blouin">Marie-José Blouin</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Parisotto, Maxime" sort="Parisotto, Maxime" uniqKey="Parisotto M" first="Maxime" last="Parisotto">Maxime Parisotto</name>
<affiliation wicri:level="1">
<nlm:affiliation>Département de Chimie, Université de Montréal, Montréal, QC H3C 3J7, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Département de Chimie, Université de Montréal, Montréal, QC H3C 3J7</wicri:regionArea>
<wicri:noRegion>QC H3C 3J7</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Papavasiliou, Vasilios" sort="Papavasiliou, Vasilios" uniqKey="Papavasiliou V" first="Vasilios" last="Papavasiliou">Vasilios Papavasiliou</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lavoie, Cynthia" sort="Lavoie, Cynthia" uniqKey="Lavoie C" first="Cynthia" last="Lavoie">Cynthia Lavoie</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Larsson, Ola" sort="Larsson, Ola" uniqKey="Larsson O" first="Ola" last="Larsson">Ola Larsson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, 171 16 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, 171 16 Stockholm</wicri:regionArea>
<wicri:noRegion>171 16 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ohh, Michael" sort="Ohh, Michael" uniqKey="Ohh M" first="Michael" last="Ohh">Michael Ohh</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Laboratory Medicine and Pathobiology and Department of Biochemistry, University of Toronto, Toronto, ON M5S1A8, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Laboratory Medicine and Pathobiology and Department of Biochemistry, University of Toronto, Toronto, ON M5S1A8</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ferreira, Tiago" sort="Ferreira, Tiago" uniqKey="Ferreira T" first="Tiago" last="Ferreira">Tiago Ferreira</name>
<affiliation wicri:level="1">
<nlm:affiliation>McGill University Centre for Research in Neuroscience, Montreal General Hospital, Montreal, QC H3G 1A4, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>McGill University Centre for Research in Neuroscience, Montreal General Hospital, Montreal, QC H3G 1A4</wicri:regionArea>
<wicri:noRegion>QC H3G 1A4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Greenwood, Celia" sort="Greenwood, Celia" uniqKey="Greenwood C" first="Celia" last="Greenwood">Celia Greenwood</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC H3A 1A3, Canada; Department of Human Genetics, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC H3A 1A3, Canada; Department of Human Genetics, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bridon, Gaelle" sort="Bridon, Gaelle" uniqKey="Bridon G" first="Gaëlle" last="Bridon">Gaëlle Bridon</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Avizonis, Daina" sort="Avizonis, Daina" uniqKey="Avizonis D" first="Daina" last="Avizonis">Daina Avizonis</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ferbeyre, Gerardo" sort="Ferbeyre, Gerardo" uniqKey="Ferbeyre G" first="Gerardo" last="Ferbeyre">Gerardo Ferbeyre</name>
<affiliation wicri:level="1">
<nlm:affiliation>Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, QC H3C 3J7, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, QC H3C 3J7</wicri:regionArea>
<wicri:noRegion>QC H3C 3J7</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Siegel, Peter" sort="Siegel, Peter" uniqKey="Siegel P" first="Peter" last="Siegel">Peter Siegel</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jones, Russell G" sort="Jones, Russell G" uniqKey="Jones R" first="Russell G" last="Jones">Russell G. Jones</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Muller, William" sort="Muller, William" uniqKey="Muller W" first="William" last="Muller">William Muller</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ursini Siegel, Josie" sort="Ursini Siegel, Josie" uniqKey="Ursini Siegel J" first="Josie" last="Ursini-Siegel">Josie Ursini-Siegel</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="St Pierre, Julie" sort="St Pierre, Julie" uniqKey="St Pierre J" first="Julie" last="St-Pierre">Julie St-Pierre</name>
<affiliation wicri:level="4">
<nlm:affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, Microbiology, and Immunology, Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, Microbiology, and Immunology, Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1H 8M5</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pollak, Michael" sort="Pollak, Michael" uniqKey="Pollak M" first="Michael" last="Pollak">Michael Pollak</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada. Electronic address: michael.pollak@mcgill.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Topisirovic, Ivan" sort="Topisirovic, Ivan" uniqKey="Topisirovic I" first="Ivan" last="Topisirovic">Ivan Topisirovic</name>
<affiliation wicri:level="4">
<nlm:affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada. Electronic address: ivan.topisirovic@mcgill.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cell metabolism</title>
<idno type="eISSN">1932-7420</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adaptor Proteins, Signal Transducing (metabolism)</term>
<term>Amino Acids (metabolism)</term>
<term>Animals (MeSH)</term>
<term>Antineoplastic Combined Chemotherapy Protocols (pharmacology)</term>
<term>Biguanides (pharmacology)</term>
<term>Drug Resistance, Neoplasm (MeSH)</term>
<term>Eukaryotic Initiation Factors (metabolism)</term>
<term>Gene Expression Regulation, Neoplastic (MeSH)</term>
<term>HCT116 Cells (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)</term>
<term>K562 Cells (MeSH)</term>
<term>Mechanistic Target of Rapamycin Complex 1 (metabolism)</term>
<term>Mice (MeSH)</term>
<term>Mice, Nude (MeSH)</term>
<term>Neoplasms (drug therapy)</term>
<term>Neoplasms (metabolism)</term>
<term>Phosphoproteins (metabolism)</term>
<term>Protein Kinase Inhibitors (pharmacology)</term>
<term>RNA, Messenger (metabolism)</term>
<term>Signal Transduction (drug effects)</term>
<term>Xenograft Model Antitumor Assays (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ARN messager (métabolisme)</term>
<term>Acides aminés (métabolisme)</term>
<term>Animaux (MeSH)</term>
<term>Biguanides (pharmacologie)</term>
<term>Cellules HCT116 (MeSH)</term>
<term>Cellules K562 (MeSH)</term>
<term>Complexe-1 cible mécanistique de la rapamycine (métabolisme)</term>
<term>Facteurs d'initiation eucaryotes (métabolisme)</term>
<term>Humains (MeSH)</term>
<term>Inhibiteurs de protéines kinases (pharmacologie)</term>
<term>Phosphoprotéines (métabolisme)</term>
<term>Protocoles de polychimiothérapie antinéoplasique (pharmacologie)</term>
<term>Protéines adaptatrices de la transduction du signal (métabolisme)</term>
<term>Régulation de l'expression des gènes tumoraux (MeSH)</term>
<term>Résistance aux médicaments antinéoplasiques (MeSH)</term>
<term>Souris (MeSH)</term>
<term>Souris nude (MeSH)</term>
<term>Sous-unité alpha du facteur-1 induit par l'hypoxie (métabolisme)</term>
<term>Tests d'activité antitumorale sur modèle de xénogreffe (MeSH)</term>
<term>Transduction du signal (effets des médicaments et des substances chimiques)</term>
<term>Tumeurs (métabolisme)</term>
<term>Tumeurs (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Adaptor Proteins, Signal Transducing</term>
<term>Amino Acids</term>
<term>Eukaryotic Initiation Factors</term>
<term>Hypoxia-Inducible Factor 1, alpha Subunit</term>
<term>Mechanistic Target of Rapamycin Complex 1</term>
<term>Phosphoproteins</term>
<term>RNA, Messenger</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Transduction du signal</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>ARN messager</term>
<term>Acides aminés</term>
<term>Complexe-1 cible mécanistique de la rapamycine</term>
<term>Facteurs d'initiation eucaryotes</term>
<term>Phosphoprotéines</term>
<term>Protéines adaptatrices de la transduction du signal</term>
<term>Sous-unité alpha du facteur-1 induit par l'hypoxie</term>
<term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Biguanides</term>
<term>Inhibiteurs de protéines kinases</term>
<term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacology" xml:lang="en">
<term>Antineoplastic Combined Chemotherapy Protocols</term>
<term>Biguanides</term>
<term>Protein Kinase Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Drug Resistance, Neoplasm</term>
<term>Gene Expression Regulation, Neoplastic</term>
<term>HCT116 Cells</term>
<term>Humans</term>
<term>K562 Cells</term>
<term>Mice</term>
<term>Mice, Nude</term>
<term>Xenograft Model Antitumor Assays</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules HCT116</term>
<term>Cellules K562</term>
<term>Humains</term>
<term>Régulation de l'expression des gènes tumoraux</term>
<term>Résistance aux médicaments antinéoplasiques</term>
<term>Souris</term>
<term>Souris nude</term>
<term>Tests d'activité antitumorale sur modèle de xénogreffe</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is increasing interest in therapeutically exploiting metabolic differences between normal and cancer cells. We show that kinase inhibitors (KIs) and biguanides synergistically and selectively target a variety of cancer cells. Synthesis of non-essential amino acids (NEAAs) aspartate, asparagine, and serine, as well as glutamine metabolism, are major determinants of the efficacy of KI/biguanide combinations. The mTORC1/4E-BP axis regulates aspartate, asparagine, and serine synthesis by modulating mRNA translation, while ablation of 4E-BP1/2 substantially decreases sensitivity of breast cancer and melanoma cells to KI/biguanide combinations. Efficacy of the KI/biguanide combinations is also determined by HIF-1α-dependent perturbations in glutamine metabolism, which were observed in VHL-deficient renal cancer cells. This suggests that cancer cells display metabolic plasticity by engaging non-redundant adaptive mechanisms, which allows them to survive therapeutic insults that target cancer metabolism.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">30244971</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>10</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>05</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1932-7420</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2018</Year>
<Month>12</Month>
<Day>04</Day>
</PubDate>
</JournalIssue>
<Title>Cell metabolism</Title>
<ISOAbbreviation>Cell Metab</ISOAbbreviation>
</Journal>
<ArticleTitle>Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.</ArticleTitle>
<Pagination>
<MedlinePgn>817-832.e8</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1550-4131(18)30566-7</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmet.2018.09.001</ELocationID>
<Abstract>
<AbstractText>There is increasing interest in therapeutically exploiting metabolic differences between normal and cancer cells. We show that kinase inhibitors (KIs) and biguanides synergistically and selectively target a variety of cancer cells. Synthesis of non-essential amino acids (NEAAs) aspartate, asparagine, and serine, as well as glutamine metabolism, are major determinants of the efficacy of KI/biguanide combinations. The mTORC1/4E-BP axis regulates aspartate, asparagine, and serine synthesis by modulating mRNA translation, while ablation of 4E-BP1/2 substantially decreases sensitivity of breast cancer and melanoma cells to KI/biguanide combinations. Efficacy of the KI/biguanide combinations is also determined by HIF-1α-dependent perturbations in glutamine metabolism, which were observed in VHL-deficient renal cancer cells. This suggests that cancer cells display metabolic plasticity by engaging non-redundant adaptive mechanisms, which allows them to survive therapeutic insults that target cancer metabolism.</AbstractText>
<CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hulea</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gravel</LastName>
<ForeName>Simon-Pierre</ForeName>
<Initials>SP</Initials>
<AffiliationInfo>
<Affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Faculté de Pharmacie, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, QC, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morita</LastName>
<ForeName>Masahiro</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Medicine and Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Institute of Resource Developmental and Analysis, Kumamoto University, Kumamoto 860-8111, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cargnello</LastName>
<ForeName>Marie</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Centre de Recherche en Cancérologie de Toulouse, 31100 Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Uchenunu</LastName>
<ForeName>Oro</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Im</LastName>
<ForeName>Young Kyuen</ForeName>
<Initials>YK</Initials>
<AffiliationInfo>
<Affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lehuédé</LastName>
<ForeName>Camille</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ma</LastName>
<ForeName>Eric H</ForeName>
<Initials>EH</Initials>
<AffiliationInfo>
<Affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leibovitch</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McLaughlan</LastName>
<ForeName>Shannon</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blouin</LastName>
<ForeName>Marie-José</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Parisotto</LastName>
<ForeName>Maxime</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Département de Chimie, Université de Montréal, Montréal, QC H3C 3J7, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Papavasiliou</LastName>
<ForeName>Vasilios</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lavoie</LastName>
<ForeName>Cynthia</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Larsson</LastName>
<ForeName>Ola</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, 171 16 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohh</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Laboratory Medicine and Pathobiology and Department of Biochemistry, University of Toronto, Toronto, ON M5S1A8, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferreira</LastName>
<ForeName>Tiago</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>McGill University Centre for Research in Neuroscience, Montreal General Hospital, Montreal, QC H3G 1A4, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Greenwood</LastName>
<ForeName>Celia</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC H3A 1A3, Canada; Department of Human Genetics, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bridon</LastName>
<ForeName>Gaëlle</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Avizonis</LastName>
<ForeName>Daina</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferbeyre</LastName>
<ForeName>Gerardo</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, QC H3C 3J7, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Siegel</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jones</LastName>
<ForeName>Russell G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Muller</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ursini-Siegel</LastName>
<ForeName>Josie</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>St-Pierre</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, Microbiology, and Immunology, Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pollak</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada. Electronic address: michael.pollak@mcgill.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Topisirovic</LastName>
<ForeName>Ivan</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Lady Davis Institute, SMBD JGH, McGill University, Montreal, QC H3A 1A3, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada. Electronic address: ivan.topisirovic@mcgill.ca.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 CA202021</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>FDN-148373</GrantID>
<Agency>CIHR</Agency>
<Country>Canada</Country>
</Grant>
<Grant>
<GrantID>MOP-363027</GrantID>
<Agency>CIHR</Agency>
<Country>Canada</Country>
</Grant>
<Grant>
<GrantID> MOP-111143</GrantID>
<Agency>CIHR</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>09</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cell Metab</MedlineTA>
<NlmUniqueID>101233170</NlmUniqueID>
<ISSNLinking>1550-4131</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001645">Biguanides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C087000">EIF4EBP1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C104151">EIF4EBP2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D039642">Eukaryotic Initiation Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C497442">HIF1A protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051795">Hypoxia-Inducible Factor 1, alpha Subunit</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D000076222">Mechanistic Target of Rapamycin Complex 1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001645" MajorTopicYN="N">Biguanides</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019008" MajorTopicYN="Y">Drug Resistance, Neoplasm</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D039642" MajorTopicYN="N">Eukaryotic Initiation Factors</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045325" MajorTopicYN="N">HCT116 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051795" MajorTopicYN="N">Hypoxia-Inducible Factor 1, alpha Subunit</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020014" MajorTopicYN="N">K562 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000076222" MajorTopicYN="N">Mechanistic Target of Rapamycin Complex 1</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">HIF-1α</Keyword>
<Keyword MajorTopicYN="Y">biguanide</Keyword>
<Keyword MajorTopicYN="Y">cancer</Keyword>
<Keyword MajorTopicYN="Y">kinase inhibitor</Keyword>
<Keyword MajorTopicYN="Y">mRNA translation</Keyword>
<Keyword MajorTopicYN="Y">mTORC1</Keyword>
<Keyword MajorTopicYN="Y">metabolic plasticity</Keyword>
<Keyword MajorTopicYN="Y">metabolism</Keyword>
<Keyword MajorTopicYN="Y">non-essential amino acids</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>07</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2018</Year>
<Month>05</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>08</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>10</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30244971</ArticleId>
<ArticleId IdType="pii">S1550-4131(18)30566-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.cmet.2018.09.001</ArticleId>
<ArticleId IdType="pmc">PMC7252493</ArticleId>
<ArticleId IdType="mid">NIHMS1507297</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Cell Rep. 2017 Jun 13;19(11):2289-2303</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28614715</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem J. 2014 Sep 15;462(3):475-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25017630</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2016 Mar 8;23(3):517-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26853747</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2017 Feb 9;168(4):657-669</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28187287</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2013 Oct 17;4:e865</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24136229</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Natl Cancer Inst. 1973 Nov;51(5):1417-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4357758</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2018 Feb 15;554(7692):378-381</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29414946</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2013 Mar 5;17(3):372-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23473032</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genome Res. 2016 May;26(5):636-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26984228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 1981 May;41(5):1751-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7214343</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1999 May 20;399(6733):271-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10353251</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):537-551</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27890529</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 2016 Aug 1;214(3):249-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27458133</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem J. 1995 Nov 15;312 ( Pt 1):163-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7492307</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 2008 Mar 19;27(6):910-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18273058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Cell. 2013 Mar 18;23(3):263-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23518341</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharmacol Exp Ther. 2006 Oct;319(1):1-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16670349</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):8977-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22611195</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2013 May 23;153(5):1064-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23706743</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cancer Ther. 2008 Jan;7(1):110-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18202014</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Vis Exp. 2014 May 17;(87):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24893926</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biol. 2007 Sep;27(18):6361-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17636013</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):239-245</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28526262</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Cancer Res. 2016 May 01;6(5):981-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27293993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2016 Sep 15;76(18):5201-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27587539</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2013 May 31;288(22):15865-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23585570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Soc Trans. 2002 Nov;30(Pt 6):1059-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12440972</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Breast Cancer Res Treat. 2011 Apr;126(2):355-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20458531</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2012 Dec 1;72(23):6257-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23041548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2014 Mar;14(3):166-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24481336</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Cell. 2018 Jan 8;33(1):91-107.e6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29316436</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2016 Apr 12;23(4):569-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27076070</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2015 Jul 30;162(3):540-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26232224</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci STKE. 2007 Oct 09;2007(407):cm8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17925579</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2014 Dec 15;74(24):7521-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25377470</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cancer. 2018 Feb 19;17(1):27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29455660</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2014 Oct 23;56(2):205-218</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25242145</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2013 Apr 15;304(8):E789-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23403946</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2017 Aug 09;8:939</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28848547</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2009 Aug 06;4(8):e6529</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19657394</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Genet. 2015 Dec;47(12):1475-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26482881</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2015 Apr;14(4):261-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25743081</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18226-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24145418</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2016 Apr 12;23(4):567-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27076069</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Elife. 2015 Oct 24;4:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26499495</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2014 Feb 4;19(2):285-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24506869</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2016 Apr 14;532(7598):255-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27049945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 1975 Mar;45(3):321-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">163658</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hematol Oncol. 2016 Aug 31;9(1):76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27581375</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2015 Oct;1847(10):1254-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26143176</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2011 Nov 20;481(7381):385-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22101431</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2013 Nov 5;18(5):698-711</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24206664</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Elife. 2014 May 13;3:e02242</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24843020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Metab. 2014 Aug 28;2:12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25184038</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cancer. 2016 Dec 19;15(1):83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27993170</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2006 Dec 28;355(26):2733-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17192538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Cell Biol. 2014 Jun;6(3):255-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24627160</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Chem Biol. 2016 Oct;12(10):779-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27479743</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Invest Dermatol. 2017 May;137(5):1135-1143</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28143781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gastroenterology. 2008 Jan;134(1):156-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18166353</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Oncol. 2015 Jul;16(7):839-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26067687</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hematol Oncol. 2016 Sep 21;9(1):91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27655410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2013 Sep;123(9):3664-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23999440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 1967 Nov 27;202(9):882-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5234350</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Enzyme Regul. 1984;22:325-400</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6089514</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2010 May 28;328(5982):1172-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20508131</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2013 Feb 15;339(6121):823-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23287722</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Enzymologia. 1966 Jun 30;30(6):367-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6005411</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2018 Jul;24(7):1036-1046</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29892070</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2010 Mar 15;70(6):2465-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20215500</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2015 Apr 23;34(17):2239-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24931163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2008 May 10;26(14):2285-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18467719</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2012 May 10;30(14):1628-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22454415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2016 Apr 1;291(14):7357-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26846855</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2015 Feb;125(2):687-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25607840</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2016 Apr 04;7:11127</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27040916</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2014 Jun;124(6):2640-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24762438</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Adv. 2016 May 27;2(5):e1600200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27386546</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Cycle. 2008 Dec;7(23):3747-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19029832</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>France</li>
<li>Japon</li>
<li>Suède</li>
</country>
<region>
<li>Midi-Pyrénées</li>
<li>Occitanie (région administrative)</li>
<li>Ontario</li>
<li>Québec</li>
</region>
<settlement>
<li>Montréal</li>
<li>Toronto</li>
<li>Toulouse</li>
</settlement>
<orgName>
<li>Université McGill</li>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Québec">
<name sortKey="Hulea, Laura" sort="Hulea, Laura" uniqKey="Hulea L" first="Laura" last="Hulea">Laura Hulea</name>
</region>
<name sortKey="Avizonis, Daina" sort="Avizonis, Daina" uniqKey="Avizonis D" first="Daina" last="Avizonis">Daina Avizonis</name>
<name sortKey="Blouin, Marie Jose" sort="Blouin, Marie Jose" uniqKey="Blouin M" first="Marie-José" last="Blouin">Marie-José Blouin</name>
<name sortKey="Bridon, Gaelle" sort="Bridon, Gaelle" uniqKey="Bridon G" first="Gaëlle" last="Bridon">Gaëlle Bridon</name>
<name sortKey="Ferbeyre, Gerardo" sort="Ferbeyre, Gerardo" uniqKey="Ferbeyre G" first="Gerardo" last="Ferbeyre">Gerardo Ferbeyre</name>
<name sortKey="Ferreira, Tiago" sort="Ferreira, Tiago" uniqKey="Ferreira T" first="Tiago" last="Ferreira">Tiago Ferreira</name>
<name sortKey="Gravel, Simon Pierre" sort="Gravel, Simon Pierre" uniqKey="Gravel S" first="Simon-Pierre" last="Gravel">Simon-Pierre Gravel</name>
<name sortKey="Greenwood, Celia" sort="Greenwood, Celia" uniqKey="Greenwood C" first="Celia" last="Greenwood">Celia Greenwood</name>
<name sortKey="Im, Young Kyuen" sort="Im, Young Kyuen" uniqKey="Im Y" first="Young Kyuen" last="Im">Young Kyuen Im</name>
<name sortKey="Jones, Russell G" sort="Jones, Russell G" uniqKey="Jones R" first="Russell G" last="Jones">Russell G. Jones</name>
<name sortKey="Lavoie, Cynthia" sort="Lavoie, Cynthia" uniqKey="Lavoie C" first="Cynthia" last="Lavoie">Cynthia Lavoie</name>
<name sortKey="Lehuede, Camille" sort="Lehuede, Camille" uniqKey="Lehuede C" first="Camille" last="Lehuédé">Camille Lehuédé</name>
<name sortKey="Leibovitch, Matthew" sort="Leibovitch, Matthew" uniqKey="Leibovitch M" first="Matthew" last="Leibovitch">Matthew Leibovitch</name>
<name sortKey="Ma, Eric H" sort="Ma, Eric H" uniqKey="Ma E" first="Eric H" last="Ma">Eric H. Ma</name>
<name sortKey="Mclaughlan, Shannon" sort="Mclaughlan, Shannon" uniqKey="Mclaughlan S" first="Shannon" last="Mclaughlan">Shannon Mclaughlan</name>
<name sortKey="Muller, William" sort="Muller, William" uniqKey="Muller W" first="William" last="Muller">William Muller</name>
<name sortKey="Ohh, Michael" sort="Ohh, Michael" uniqKey="Ohh M" first="Michael" last="Ohh">Michael Ohh</name>
<name sortKey="Papavasiliou, Vasilios" sort="Papavasiliou, Vasilios" uniqKey="Papavasiliou V" first="Vasilios" last="Papavasiliou">Vasilios Papavasiliou</name>
<name sortKey="Parisotto, Maxime" sort="Parisotto, Maxime" uniqKey="Parisotto M" first="Maxime" last="Parisotto">Maxime Parisotto</name>
<name sortKey="Pollak, Michael" sort="Pollak, Michael" uniqKey="Pollak M" first="Michael" last="Pollak">Michael Pollak</name>
<name sortKey="Siegel, Peter" sort="Siegel, Peter" uniqKey="Siegel P" first="Peter" last="Siegel">Peter Siegel</name>
<name sortKey="St Pierre, Julie" sort="St Pierre, Julie" uniqKey="St Pierre J" first="Julie" last="St-Pierre">Julie St-Pierre</name>
<name sortKey="Topisirovic, Ivan" sort="Topisirovic, Ivan" uniqKey="Topisirovic I" first="Ivan" last="Topisirovic">Ivan Topisirovic</name>
<name sortKey="Uchenunu, Oro" sort="Uchenunu, Oro" uniqKey="Uchenunu O" first="Oro" last="Uchenunu">Oro Uchenunu</name>
<name sortKey="Ursini Siegel, Josie" sort="Ursini Siegel, Josie" uniqKey="Ursini Siegel J" first="Josie" last="Ursini-Siegel">Josie Ursini-Siegel</name>
</country>
<country name="Japon">
<noRegion>
<name sortKey="Morita, Masahiro" sort="Morita, Masahiro" uniqKey="Morita M" first="Masahiro" last="Morita">Masahiro Morita</name>
</noRegion>
</country>
<country name="France">
<region name="Occitanie (région administrative)">
<name sortKey="Cargnello, Marie" sort="Cargnello, Marie" uniqKey="Cargnello M" first="Marie" last="Cargnello">Marie Cargnello</name>
</region>
</country>
<country name="Suède">
<noRegion>
<name sortKey="Larsson, Ola" sort="Larsson, Ola" uniqKey="Larsson O" first="Ola" last="Larsson">Ola Larsson</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000433 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000433 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:30244971
   |texte=   Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:30244971" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020